Clinical Trial

Research on the Role of Probiotics in Human Intestinal Health

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 20, 2025 (before its estimated September 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
Evaluate the efectiveness and safety of Bifidobacterium bifidum BBi32 as a food supplement compared to a placebo in improving intestinal andimmune functions in healthy adults.
Trial Details
NCT Number NCT06886711
Lead Sponsor Wecare Probiotics Co., Ltd.
Conditions Intestinal Microbiota
Enrollment 45 participants
Start Date 2025-03-10
Primary Completion 2025-09-30 (estimated)
Study Completion 2025-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-03-20